| Literature DB >> 34328581 |
Michele Correale1, Francesca Croella2, Alessandra Leopizzi2, Pietro Mazzeo2, Lucia Tricarico2, Adriana Mallardi2, Martino Fortunato2, Michele Magnesa2, Vincenzo Ceci2, Alessandra Puteo1, Massimo Iacoviello2, Matteo Di Biase2, Natale Daniele Brunetti3.
Abstract
COVID-19 pandemic has negatively impacted the management of patients with acute and chronic cardiovascular disease: acute coronary syndrome patients were often not timely reperfused, heart failure patients not adequately followed up and titrated, atrial arrhythmias not efficaciously treated and became chronic. New phenotypes of cardiovascular patients were more and more frequent during COVID-19 pandemic and are expected to be even more frequent in the next future in the new world shaped by the pandemic. We therefore aimed to briefly summarize the main changes in the phenotype of cardiovascular patients in the COVID-19 era, focusing on new clinical challenges and possible therapeutic options.Entities:
Keywords: Acute coronary syndrome; Arrhythmias; Cardiovascular disease; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Thrombosis; Heart failure
Year: 2021 PMID： 34328581 DOI： 10.1007/s10557-021-07217-8
Source DB: PubMed Journal: Cardiovasc Drugs Ther ISSN： 0920-3206 Impact factor: 3.727